Healthtech Startups
16,921 companies tagged Healthtech, with their investors and founders.
NฤRx Biosciences develops small molecule inhibitors targeting DNA damage sensor proteins for cancer treatment, with initial focus on difficult-to-treat lung and ovarian cancers. The company builds on two decades of academic research from Indiana University's School of Medicine on DNA damage and repair mechanisms.
2 investors
Nesa Medtech develops GYIDE, a minimally invasive, uterus-preserving medical device that uses a guidance and planning system to deliver treatment that shrinks uterine fibroids without cutting or suturing. The company targets women's health, offering an alternative to existing surgical and non-surgical treatments for uterine fibroids.
2 investors
Neteera develops contactless sensor-based technology for continuous patient monitoring, using AI and signal processing to support clinical workflows and remote care. It sells to healthcare providers, including in the North American market.
2 investors
Netsmart provides behavioral health information technology solutions and advocacy services supporting the expansion of Certified Community Behavioral Health Clinics and integrated mental health care delivery. The company engages in legislative advocacy and industry coalition work to advance behavioral health IT infrastructure and financing policies.
2 investors
Neuraptive is a biotechnology company staffed by professionals with expertise in research and development, manufacturing, and commercialization in the pharmaceutical industry.
2 investors
Neuraura Biotech develops proprietary 3D micro-electrode and microsensor technology for high-fidelity neural recording and percutaneous stimulation, used to improve diagnostic and therapeutic solutions for neurological, psychiatric and sensory conditions. The company commercializes technology transferred from the University of Calgary, with a stated focus on chronic, underserved health conditions including women's health.
2 investors
Neurelis is a neuroscience-based biopharmaceutical company that develops treatments for people living with neurological conditions such as epilepsy. It also maintains a proprietary drug delivery and stabilization technology portfolio applicable to proteins, peptides, and small and large molecules.
2 investors
2 investors
neurocare group operates a network of over 20 clinics across Europe, the United States, and Australia offering personalized mental health treatments such as TMS, neurofeedback, and tDCS for conditions including depression, ADHD, OCD, and sleep disorders. It also provides a Digital Therapy Platform and an online academy that trains third-party clinicians in its treatment protocols.
2 investors
Neuroglee provides remote dementia and memory care through a care team of navigators, clinicians, social workers, and pharmacists who coordinate treatment, offer 24/7 support, and connect patients and caregivers with community resources. It also helps manage other long-term conditions and serious illnesses for patients and their families at home.
2 investors
Neurogram develops AI-powered solutions for neurological diagnostics using brain-computer interface technology and EEG analysis. The company serves neurologists and healthcare providers seeking precision diagnostic tools grounded in neuroscience research.
2 investors
Neuroharmonics is developing a non-invasive neuromodulation platform based on focused transcranial ultrasound to modulate specific brain circuits for treating neurological and psychiatric conditions and enabling brain-computer interaction. The company operates in the neurotech and medical technology space.
2 investors
NeuroIntact develops VCool, a portable system for precise core body temperature modulation in hospitalized patients. The company serves clinical markets including military and commercial hospitals, operating in the medical device and healthcare technology sector.
2 investors
Neurolase develops AI-powered technology for brain surgery, aiming to improve surgical precision and patient outcomes in neurosurgery, particularly for brain tumor resection. The company is built by a team of clinicians, scientists and engineers to set a new intraoperative standard for neurosurgeons.
2 investors
2 investors
NeuroSonic develops a handheld, non-invasive device that assesses stroke risk by analyzing carotid artery blood flow, enabling clinicians to determine which patients require further vascular imaging. The device is designed for use in clinical settings to accelerate stroke-risk assessment and improve prevention.
2 investors
Neurosynaptic Communications provides customized healthcare delivery solutions and telemedicine services designed for primary healthcare centers and underserved regions. The company combines technology platforms like ReMeDiยฎ Kits and Platform with hands-on service delivery to improve healthcare access, affordability, and operational efficiency.
2 investors
Neurovalens develops medical devices using neuromodulation technology to address health conditions including obesity and anxiety disorders. The company conducts research and development activities supported by European funding programs.
2 investors
NeuroVasc Technologies develops catheter-based medical devices designed to treat stroke and other neurological conditions. The company serves patients and healthcare providers requiring neurovascular interventions.
2 investors
NeuroWyzr is a clinical neuroscience company that builds gamified digital assessments and care products for early detection, diagnosis, monitoring and prevention of brain decline. Its offerings use clinical evidence and AI-powered analytics to support brain health and mental wellbeing, with a focus on the Asia-Pacific market.
2 investors
NeuroX1 is an Austin-based biotech building a generative-AI target ID and drug discovery platform for neurological disorders.
2 investors
Nevro develops spinal cord stimulation systems for pain management, offering the Senza Trial Stimulator with high-frequency therapy options and wireless capability for patient trials and treatment.
2 investors
New View Medical develops single-use surgical visualization devices designed for minimally invasive procedures. The company targets healthcare systems seeking to reduce costs while improving clinical outcomes.
2 investors
NewDays offers a clinician-supervised cognitive treatment program combining telehealth support with AI-guided brain training exercises, designed for individuals with mild cognitive impairment or dementia. The program is delivered at home and aims to improve cognitive function, mental health, and delay symptom progression.
2 investors